Scientists are developing a new way to identify the unique chemical 'fingerprints' for different types of breast cancers. These new chemical footprints will be used to train AI software -- creating a new tool for rapid and accurate diagnosis of breast cancers.
In an article published in the peer-reviewed SPIE publication Journal of Biomedical Optics (JBO), 'Influence of neoadjuvant chemotherapy on diffuse reflectance spectra of tissue in breast surgery specimens,' research observed across 92 ex vivo breast specimens suggests that there is little to no impact on the optical signatures of breast tissue after neoadjuvant chemotherapy.
If your DNA is a cookbook, a single gene is a recipe. But it's a flexible recipe that if edited one way can make a pie; edited another way can make a cake. And that difference can mean cancer, as a team of researchers who looked at those gene editors writes in the 26 November issue of Cell Reports.
Cancers found in patients undergoing annual mammography screening are smaller and less advanced than those found in patients undergoing screenings every two years, according to a new study.
It is known that metabolic syndrome (high blood pressure, high blood sugar, excess abdominal fat, high triglyceride level, and/or unhealthy cholesterol levels) is associated with an increased risk of cardiovascular disease. When patients with metabolic syndrome reverse the syndrome, this risk decreases. Findings from a nationwide population-based cohort study are published in Annals of Internal Medicine.
The largest and most comprehensive study looking at deaths from cardiovascular disease among patients with 28 types of cancer with over 40 years of data has shown that more than one in ten cancer patients do not die from their cancer but from heart and blood vessel problems instead. The paper and accompanying editorial are published in the European Heart Journal.
Approximately 10% of breast cancer patients treated with lumpectomy (breast-conserving surgery [BCS]) and whole-breast radiation (WBI) will have a subsequent in-breast local recurrence of cancer (IBTR) when followed long term.
The trastuzumab biosimilar HLX02 achieved similar overall response rate to reference trastuzumab in women with human epidermal growth factor receptor 2-positive (HER2+) recurrent or previously untreated metastatic breast cancer, according to a large, randomised phase III study reported at the ESMO Asia 2019 Congress.
Opioids play an important role in how cancer patients manage pain, but the ongoing opioid epidemic has raised concerns about their potential for abuse. A new study in the Journal of the National Cancer Institute reveals that several factors are associated with a risk for persistent opioid use, including younger age, white race, unemployment at the time of cancer diagnosis, lower median income, and current or prior tobacco use.
Researchers from the CIBER-BBN and the Universitat Autònoma de Barcelona use bioengineering to design non-toxic drug-release granules to be administered locally and with prolonged therapeutic effects.